Title: UKHDS UKPDS: UK Hypertension in Diabetes Study
1 UKHDS (UKPDS) UK Hypertension in Diabetes
Study
-
- Purpose
- To determine whether tight control of blood
pressure (aiming for BP lt150/85 mmHg)
reduces/prevents complications and reduces
mortality in hypertensive patients with type 2
diabetes - Reference
- UK Prospective Diabetes Study Group. Tight blood
pressure control and risk of macrovascular and
microvascular complications in type 2 diabetes
UKPDS 38. BMJ 199831770313.
2UKHDS (UKPDS) UK Hypertension in Diabetes
Study- TRIAL DESIGN -
-
- Design
- Randomized, open, controlled trial
- Patients
- 1148 hypertensive patients with type 2 diabetes,
mean age 56 years, mean BP at entry 160/94 mmHg -
- Follow up and primary endpoint
- Mean follow up 8.4 years. Primary endpoints
morbidity and mortality related to diabetes and
all-cause mortality - Treatment
- Tight control of BP with ACE inhibitor
(captopril) or beta-blocker (atenolol) aiming for
BP lt150/85 mmHg, or less tight control aiming for
BP lt180/105 mmHg. Other agents added if control
criteria not met (frusemide, nifedipine,
methyldopa and prazosin) -
3UKHDS (UKPDS) UK Hypertension in Diabetes
Study- RESULTS BP Control and side effects -
- Mean BP during follow up maintained at
significantly lower level in group assigned to
tight control (144/82 mmHg) than in group
assigned to less tight control (154/87 mmHg) - 29 of patients in group assigned to tight
control required three or more antihypertensive
treatments to maintain BP at target levels - No significant difference in cumulative incidence
of hypoglycemia in groups assigned to tight
(6.1) and less tight (4.4) BP control - Mean weight gain similar in both groups (1.3 and
2.0 kg, respectively, P0.13)
4UKHDS (UKPDS) UK Hypertension in Diabetes
Study- RESULTS BP Control and side effects -
Mean systolic and diastolic BP
160
Blood pressure
(mmHg)
140
100
Less tight control
(n156)
80
Tight control
(n297)
0
3
2
1
4
5
6
7
8
9
Years from randomization
UK Prospective Diabetes Study Group. BMJ
199831770313.
5UKHDS (UKPDS) UK Hypertension in Diabetes
Study- RESULTS Morbidity and mortality -
- Group assigned tight BP control had significant
reduction in - All diabetes-related endpoints combined
- Death related to diabetes
- Stroke (fatal or non-fatal)
- Microvascular end points combined (predominantly
due to significantly reduced risk of retinal
photocoagulation) - Heart failure
- Less deterioration of retinopathy and visual
acuity in group assigned tight BP control - Trends towards reduction in MI, PVD, amputation,
fatal/non-fatal renal failure and all-cause
mortality were not significant
6UKHDS (UKPDS) UK Hypertension in Diabetes
Study- RESULTS Morbidity and mortality -
Clinical events per 1000 patient years
Tight control
Less tight
Relative risk for tight
P
Clinical end point
(n758)
control (n390)
control (95 CI)
7UKHDS (UKPDS) UK Hypertension in Diabetes
Study- RESULTS Morbidity and mortality -
Progression of retinopathy and deterioration in
vision
Tight control
Less tight
Relative risk for tight
P
()
control ()
control (95 Cl)
Progression of retinopathy
by gt 2 steps
20.2
23.1
0.88 (0.60
1.29)
0.38
Median 1.5 years
27.5
36.7
0.75 (0.55
1.02)
0.019
Median 4.5 years
34.0
51.3
0.66 (0.50
0.89)
0.0038
Median 7.5 years
Deterioration in vision
by gt
3 ETDRS lines
a
Median 1.5 years
5.4
6.8
0.79 (0.39
1.62)
0.39
Median 4.5 years
7.5
8.9
0.83 (0.44
1.59)
0.47
Median 7.5 years
10.2
19.4
0.53 (0.30
0.93)
0.0036
a
ETDRS early treatment of diabetic retinopathy
study
UK Prospective Diabetes Study Group. BMJ
199831770313.
8UKHDS (UKPDS) UK Hypertension in Diabetes Study
- SUMMARY -
-
- In hypertensive patients with type 2 diabetes,
long-term tight BP control aiming to keep BP
lt150/85 mmHg by use of an ACE inhibitor or
beta-blocker (plus additional anti-hypertensive
treatment if necessary) - Achieved mean BP of 144/82 mmHg
- Reduced risk of diabetic complications and death
related to diabetes - Reduced risk of progression of diabetic
retinopathy and deterioration in visual acuity